கட்டுரை பார்மா இன்க் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from கட்டுரை பார்மா இன்க். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In கட்டுரை பார்மா இன்க் Today - Breaking & Trending Today

ESSA Pharma to Present at the Jefferies Virtual Healthcare Conference

ESSA Pharma to Present at the Jefferies Virtual Healthcare Conference
News provided by
Share this article
Share this article
HOUSTON, Texas and VANCOUVER, Canada, May 25, 2021 /PRNewswire/ - ESSA Pharma Inc. ( ESSA or the Company ) (Nasdaq: EPIX), a clinical-stage pharmaceutical company focused on developing novel therapies for the treatment of prostate cancer, today announced that Dr. David R. Parkinson, Chief Executive Officer of ESSA, will participate in a fireside chat at the upcoming Jefferies Virtual Healthcare Conference. Dr. Parkinson, along with Peter Virsik, ESSA s Chief Operating Officer, and David S. Wood, ESSA s Chief Financial Officer, will be available for one-on-one meetings. The conference will take place from June 1 – June 4, 2021. ....

United States , British Columbia , Davids Wood , Davidr Parkinson , Peter Virsik , Company Nasdaq , Pharma Inc , Chief Executive Officer , Jefferies Virtual Healthcare , Operating Officer , Financial Officer , Chat Details , Essa Pharma Inc , ஒன்றுபட்டது மாநிலங்களில் , பிரிட்டிஷ் கொலம்பியா , டேவிட்ஸ் மரம் , நிறுவனம் நாஸ்டாக் , பார்மா இன்க் , தலைமை நிர்வாகி அதிகாரி , ஜெஃப்பெரிஸ் மெய்நிகர் சுகாதாரம் , இயங்குகிறது அதிகாரி , நிதி அதிகாரி , அரட்டை விவரங்கள் , கட்டுரை பார்மா இன்க் ,

ESSA Pharma Announces Exercise of Option in Connection with Recently Completed $130 Million Financing

ESSA Pharma Announces Exercise of Option in Connection with Recently Completed $130 Million Financing
News provided by
Share this article
Share this article
VANCOUVER, BC and HOUSTON, March 4, 2021 /PRNewswire/ - ESSA Pharma Inc. ( ESSA , or the Company ) (Nasdaq: EPIX), a clinical-stage pharmaceutical company focused on developing novel therapies for the treatment of prostate cancer, today announced that the underwriters have exercised their option (the Option ) to purchase an additional 724,637 common shares in the capital of the Company (the Common Shares ), in connection with the Company s recently completed underwritten public offering of 4,830,918 Common Shares, which closed on February 22, 2021 (the Offering ). On closing of the Option, the Company will have issued 5,555,555 Common Shares pursuant to the Offering for gross proceeds of approximately $150 million. ....

United States , United Kingdom , British Columbia , Piper Sandler , Company Nasdaq , Canadian Base Shelf Prospectus , Bloom Burton Securities Inc , Company The Common , Oppenheimer Co , Exchange Commission , Pharma Inc , Bloom Burton Securities , Base Shelf , Base Shelf Prospectus , Private Securities Litigation Reform Act , Essa Pharma Inc , ஒன்றுபட்டது மாநிலங்களில் , ஒன்றுபட்டது கிஂக்டம் , பிரிட்டிஷ் கொலம்பியா , பைபர் சாண்ட்லர் , நிறுவனம் நாஸ்டாக் , கனடியன் அடித்தளம் அலமாரி ப்ரோஸ்பெக்டஸ் , பூக்கும் பர்டன் பத்திரங்கள் இன்க் , நிறுவனம் தி பொதுவானது , ஆபெந்ஹைமர் இணை , பரிமாற்றம் தரகு ,

ESSA Pharma Inc. Reports Results of Annual General and Special Meeting of Shareholders

0.10%
At the Meeting, the Shareholders also approved: (i) the re-appointment of Davidson & Company LLP, Chartered Professional Accountants, as auditors of the Company; (ii) the Company s omnibus incentive plan; (iii) an amendment to the Company s existing stock option plan (the
Amended Option Plan ) and the previous grant of stock options exercisable thereunder; and (iv) an amendment to the Company s articles.
About ESSA Pharma Inc.
ESSA is a clinical-stage pharmaceutical company focused on developing novel and proprietary therapies for the treatment of patients with prostate cancer. For more information, please visit www.essapharma.com and follow us on Twitter under @ESSAPharma.
About Prostate Cancer ....

United States , British Columbia , Scott Requadt , Alex Martin , Marella Thorell , Franklinm Berger , Richardm Glickman , Gary Sollis , Sandy Zweifach , Davidr Parkinson , Company The Shareholders , Pharma Inc , Davidson Company , Annual General Meeting , Ari Brettman , Chartered Professional Accountants , Essa Pharma Inc , ஒன்றுபட்டது மாநிலங்களில் , பிரிட்டிஷ் கொலம்பியா , அலெக்ஸ் மார்டின் , மணல் ஜுவெபச் , நிறுவனம் தி பங்குதாரர்கள் , பார்மா இன்க் , டேவிட்சன் நிறுவனம் , ஆண்டு ஜநரல் சந்தித்தல் , பட்டய ப்ரொஃபெஶநல் கணக்காளர்கள் ,

ESSA Pharma Announces Pricing of Public Offering of Common Shares

ESSA Pharma Announces Pricing of Public Offering of Common Shares
News provided by
Share this article
Share this article
VANCOUVER, BC and HOUSTON, Feb. 17, 2021 /PRNewswire/ - ESSA Pharma Inc. ( ESSA , or the Company ) (Nasdaq: EPIX), a clinical-stage pharmaceutical company focused on developing novel therapies for the treatment of prostate cancer, today announced the pricing of an underwritten public offering of 4,830,918 common shares at a public offering price of $27.00 per share, before underwriting discounts, for an aggregate offering of approximately $130.4 million (the Offering ). ESSA has granted the underwriters a 30-day option to purchase, in whole or in part, up to an additional 724,637 shares of its common shares (the Option ). The proceeds to ESSA from the Offering are expected to be approximately $121.6 million after deducting underwriting discounts and commissions and other estimated offering expenses but excluding any exercise of the Option. ES ....

United States , British Columbia , Piper Sandler , Exchange Commission , Canadian Base Shelf Prospectus , Company Nasdaq , Bloom Burton Securities Inc , Pharma Inc , Oppenheimer Co , Bloom Burton Securities , Base Shelf , Essa Pharma Inc , Banking Amp Financial Services , Health Care Amp Hospitals , Medical Pharmaceuticals , Stock Offering , ஒன்றுபட்டது மாநிலங்களில் , பிரிட்டிஷ் கொலம்பியா , பைபர் சாண்ட்லர் , பரிமாற்றம் தரகு , கனடியன் அடித்தளம் அலமாரி ப்ரோஸ்பெக்டஸ் , நிறுவனம் நாஸ்டாக் , பூக்கும் பர்டன் பத்திரங்கள் இன்க் , பார்மா இன்க் , ஆபெந்ஹைமர் இணை , பூக்கும் பர்டன் பத்திரங்கள் ,

ESSA Pharma Announces Proposed Public Offering of Common Shares

/PRNewswire/ - ESSA Pharma Inc. ("ESSA", or the "Company") (Nasdaq: EPIX), a clinical-stage pharmaceutical company focused on developing novel therapies for. ....

New York , United States , United Kingdom , British Columbia , Piper Sandler , Company Nasdaq , Canadian Base Shelf Prospectus , Bloom Burton Securities Inc , Oppenheimer Co , Exchange Commission , Prospectus Department , Equity Syndicate Prospectus Department , Piper Sandler Co , Pharma Inc , Bloom Burton Securities , Base Shelf , Base Shelf Prospectus , Private Securities Litigation Reform Act , Essa Pharma Inc , Banking Amp Financial Services , Health Care Amp Hospitals , Medical Pharmaceuticals , Stock Offering , புதியது யார்க் , ஒன்றுபட்டது மாநிலங்களில் , ஒன்றுபட்டது கிஂக்டம் ,